haematology
Blood cancers

ASCO 21: Professor John Seymour on the latest in B-cell lymphoma treatments

Discussing the latest treatments in B-cell lymphomas at this year’s virtual ASCO 2021 meeting Professor John Seymour, Director of the integrated Haematology Department of the Peter MacCallum Cancer Centre & the Royal Melbourne Hospital in Melbourne, weighed up three recently FDA approved drug classes in relapsed follicular lymphoma, marginal zone lymphoma and Waldenstrom’s macroglobulinemia. Among ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic